Vertice Pharma Growth, Revenue, Number of Employees and Funding

Overview

Location:
New Providence, NJ USA
Total Funding:N/A
Industry:Pharma
Founded:2015
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Vertice Pharma's estimated revenue is currently $7.8M per year.
  • Vertice Pharma's estimated revenue per employee is $186643

Employee Data

  • Vertice Pharma has 42 Employees.
  • Vertice Pharma grew their employee count by -7% last year.
  • Vertice Pharma currently has 1 job openings.

Executive Contacts

NameTitle
Deepa AdigaSenior Director, Regulatory Affairs and R&D Compliance
Rupinder PhullSr Director
Megan SchoepsDirector, Finance & Controller
Cheryl KamiyaAssociate Director, Regulatory Affairs
ARPAD SZECHENYIVP COMMERCIAL OPERATIONS
INDRANIL NANDIVP RESEARCH & DEVELOPMENT
Ozgur KilicChief Financial Officer
Jonathan NixAssociate Director: Commercial Finance
Ajay SainiSenior Director
Noel GreenbergerVice President, Commercial Operations

What Is Vertice Pharma?

Vertice Pharma is a specialty pharmaceuticals company focused on improving patients health. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma has global headquarters in the United Kingdom and United States headquarters in New Jersey.

keywords:N/A

42

Number of Employees

$7.8M

Revenue (est)

1

Current Jobs

-7%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TCP Reliable
$8.4M450%
Aquestive Thera...
$6.7M139-6%$76.6M
TCP Reliable
$8.4M450%
Shionogi
$96.5M5148%
Trio, An FCB He...
$8M43-2%
Vertice Pharma
$7.8M42-7%
Ortho Dermatolo...
$48.6M25912%
PRI Healthcare ...
$11.3M60-5%
TAIHO ONCOLOGY ...
$39M2089%
LEO Pharma Inc....
$46.6M2483%

Vertice Pharma News

24-Aug-19 - Sun Pharma settles Riomet patent dispute with Vertice Pharma

Sun Pharmaceutical Industries (OTCPK:SMPQY) has agreed to settle its litigation against would-be generic competitor Vertice Pharma over ...

12-Sep-19 - Bridgewater: Center of Excellence plan returning to planning board with new owner

Additional tenants include Insmed, Avantor, Nevakar, Solaris Pharma, Clinical Genomics, Matinas BioPharma, Vertice Pharma, 3D Biotek, ...

24-Aug-19 - Global Opioids Market Industry Trends and Future Insights ...

Allergan, Teva Pharmaceuticals, Mallinckrodt, Insys Therapeutics, and ... 6.1.5 Sun Pharmaceutical Industries Ltd ... 6.1.7 Vertice Pharma LLC

Vertice Pharma Executive Hires

DateNameTitleReference
2016-02-23Scott MeyersChief Operating OfficerArticle